Optical genome mapping identifies a germline retrotransposon insertion in SMARCB1 in two siblings with atypical teratoid rhabdoid tumors

被引:24
|
作者
Sabatella, Mariangela [1 ]
Mantere, Tuomo [2 ,3 ,4 ]
Waanders, Esme [5 ]
Neveling, Kornelia [2 ]
Mensenkamp, Arjen R. [2 ,3 ]
van Dijk, Freerk [1 ]
Hehir-Kwa, Jayne Y. [1 ]
Derks, Ronnie [2 ,3 ]
Kwint, Michael [2 ,3 ]
O'Gorman, Luke [2 ,3 ]
Tropa Martins, Madalena [1 ]
Gidding, Corrie E. M. [1 ]
Lequin, Maarten H. [6 ]
Kusters, Benno [7 ]
Wesseling, Pieter [1 ,8 ]
Nelen, Marcel [2 ,3 ]
Biegel, Jacklyn A. [9 ,10 ]
Hoischen, Alexander [2 ,3 ,11 ,12 ]
Jongmans, Marjolijn C. [1 ,5 ]
Kuiper, Roland P. [1 ,2 ]
机构
[1] Princess Maxima Ctr Pediat Oncol, Heidelberglaan 25, NL-3584 CS Utrecht, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands
[4] Univ Oulu, Canc & Translat Med Res Unit & Bioctr Oulu, Lab Canc Genet & Tumor Biol, Oulu, Finland
[5] Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands
[6] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands
[7] Radboud Univ Nijmegen Med Ctr, Dept Pathol, Nijmegen, Netherlands
[8] Amsterdam Univ Med Ctr, Dept Pathol, Locat VUmc & Brain Tumor Ctr Amsterdam, Amsterdam, Netherlands
[9] Childrens Hosp, Dept Pathol & Lab Med, Los Angeles, CA 90027 USA
[10] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[11] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands
[12] Radboud Univ Nijmegen Med Ctr, Radboud Ctr Infect Dis RCI, Nijmegen, Netherlands
来源
JOURNAL OF PATHOLOGY | 2021年 / 255卷 / 02期
关键词
childhood cancer predisposition; rhabdoid tumors; SMARCB1; retrotransposon; optical imaging; TERATOID/RHABDOID TUMORS; SVA ELEMENTS; MUTATIONS; GENE; PREDISPOSITION; HSNF5/INI1; VARIANT; FEATURES; INFANCY; INI1;
D O I
10.1002/path.5755
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a subset of pediatric cancers, a germline cancer predisposition is highly suspected based on clinical and pathological findings, but genetic evidence is lacking, which hampers genetic counseling and predictive testing in the families involved. We describe a family with two siblings born from healthy parents who were both neonatally diagnosed with atypical teratoid rhabdoid tumor (ATRT). This rare and aggressive pediatric tumor is associated with biallelic inactivation of SMARCB1, and in 30% of the cases, a predisposing germline mutation is involved. Whereas the tumors of both siblings showed loss of expression of SMARCB1 and acquired homozygosity of the locus, whole exome and whole genome sequencing failed to identify germline or somatic SMARCB1 pathogenic mutations. We therefore hypothesized that the insertion of a pathogenic repeat-rich structure might hamper its detection, and we performed optical genome mapping (OGM) as an alternative strategy to identify structural variation in this locus. Using this approach, an insertion of similar to 2.8 kb within intron 2 of SMARCB1 was detected. Long-range PCR covering this region remained unsuccessful, but PacBio HiFi genome sequencing identified this insertion to be a SINE-VNTR-Alu, subfamily E (SVA-E) retrotransposon element, which was present in a mosaic state in the mother. This SVA-E insertion disrupts correct splicing of the gene, resulting in loss of a functional allele. This case demonstrates the power of OGM and long-read sequencing to identify genomic variations in high-risk cancer-predisposing genes that are refractory to detection with standard techniques, thereby completing the clinical and molecular diagnosis of such complex cases and greatly improving counseling and surveillance of the families involved. (c) 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
引用
收藏
页码:202 / 211
页数:10
相关论文
共 48 条
  • [21] PREVALENCE OF GERMLINE VARIANTS IN SMARCB1 INCLUDING SOMATIC MOSAICISM IN AT/RT AND OTHER RHABDOID TUMORS
    Shirai, Ryota
    Osumi, Tomoo
    Terashima, Keita
    Kiyotani, Chikako
    Uchiyama, Meri
    Tsujimoto, Shinichi
    Yoshida, Masanori
    Yoshida, Kaoru
    Uchiyama, Toru
    Tomizawa, Daisuke
    Shioda, Yoko
    Sekiguchi, Masahiro
    Watanabe, Kenichiro
    Keino, Dai
    Ueno-Yokohata, Hitomi
    Ohki, Kentaro
    Takita, Junko
    Ito, Shuichi
    Deguchi, Takao
    Kiyokawa, Nobutaka
    Ogiwara, Hideki
    Hishiki, Tomoro
    Ogawa, Seishi
    Okita, Hajime
    Matsumoto, Kimikazu
    Yoshioka, Takako
    Kato, Motohiro
    NEURO-ONCOLOGY, 2020, 22 : 277 - 278
  • [22] ATYPICAL TERATOID RHABDOID TUMORS AND POORLY DIFFERENTIATED CHORDOMAS: DISTINCT MOLECULAR ENTITIES WITH SMARCB1/INI1 LOSS AND DISMAL PROGNOSIS
    Thomas, Christian
    Hovestadt, Volker
    Schrimpf, Daniel
    Johann, Pascal
    Bens, Susanne
    Oyen, Florian
    Vogel, Hannes
    Giangaspero, Felice
    Antonelli, Manila
    Riemenschneider, Markus
    Christine Bernardo, Marie
    Giannini, Caterina
    Din, Nasir Ud
    Perry, Arie
    Keyvani, Kathy
    van Landeghem, Frank
    Sumerauer, David
    Hauser, Peter
    Capper, David
    Korshunov, Andrey
    Jones, David T. W.
    Pfister, Stefan
    Schneppenheim, Reinhard
    Siebert, Reiner
    Fruehwald, Michael C.
    Kool, Marcel
    Hasselblatt, Martin
    NEURO-ONCOLOGY, 2016, 18 : 3 - 3
  • [23] Spatial and temporal conditions for Smarcb1 deletion determines mouse AT/RT (atypical teratoid/rhabdoid tumor) subtype
    Han, Zhi-Yan
    Andrianteranagna, Mamy
    Jesus-Lobon-Iglesias, Maria
    Tauziede-Espariat, Arnault
    Beccaria, Kevin
    Freneaux, Paul
    Waterfall, Joshua J.
    Masliah-Planchon, Julien
    Bourneix, Christine
    Pierron, Gaelle
    Leruste, Amaury
    Chauvin, Celine
    Surdez, Didier
    Varlet, Pascale
    Dufour, Christelle
    Delattre, Olivier
    Dangouloff-Ros, Volodia
    Bourdeaut, Franck
    CANCER RESEARCH, 2020, 80 (14) : 113 - 113
  • [24] SMARCB1 loss induces druggable cyclinD1deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors
    Xue, Yibo
    Zhu, Xianbing
    Meehan, Brian
    Venneti, Sriram
    Martinez, Daniel
    Morin, Genevieve
    Maiga, Rayelle, I
    Chen, Hongbo
    Papadakis, Andreas, I
    Johnson, Radia M.
    O'Sullivan, Maureen J.
    Erdreich-Epstein, Anat
    Gotlieb, Walter H.
    Park, Morag
    Judkins, Alexander R.
    Pelletier, Jerry
    Foulkes, William D.
    Rak, Janusz
    Huang, Sidong
    JOURNAL OF PATHOLOGY, 2020, 252 (01): : 77 - 87
  • [25] Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor
    Duan, Zejun
    Yao, Kun
    Yang, Shaomin
    Qu, Yanming
    Ren, Ming
    Zhang, Yongli
    Fan, Tao
    Zhao, Heqian
    Gao, Jie
    Feng, Jing
    Fan, Xiaolong
    Qi, Xueling
    MODERN PATHOLOGY, 2022, 35 (12) : 1910 - 1920
  • [26] Conventional Chondrosarcoma in a Survivor of Rhabdoid Tumor Enlarging The Spectrum of Tumors Associated With SMARCB1 Germline Mutations
    Forest, Fabien
    David, Audrey
    Arrufat, Sandrine
    Pierron, Gaelle
    Ranchere-Vince, Dominique
    Stephan, Jean-Louis
    Clemenson, Alix
    Delattre, Olivier
    Bourdeaut, Franck
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (12) : 1892 - 1896
  • [27] High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors
    Hasselblatt, Martin
    Isken, Sarah
    Linge, Anna
    Eikmeier, Kristin
    Jeibmann, Astrid
    Oyen, Florian
    Nagel, Inga
    Richter, Julia
    Bartelheim, Kerstin
    Kordes, Uwe
    Schneppenheim, Reinhard
    Fruehwald, Michael
    Siebert, Reiner
    Paulus, Werner
    GENES CHROMOSOMES & CANCER, 2013, 52 (02): : 185 - 190
  • [28] LIN28B is highly expressed in atypical teratoid/rhabdoid tumor (AT/RT) and suppressed through the restoration of SMARCB1
    Seung Ah Choi
    Seung-Ki Kim
    Ji Yeoun Lee
    Kyu-Chang Wang
    Chanhee Lee
    Ji Hoon Phi
    Cancer Cell International, 16
  • [29] LIN28B is highly expressed in atypical teratoid/rhabdoid tumor (AT/RT) and suppressed through the restoration of SMARCB1
    Choi, Seung Ah
    Kim, Seung-Ki
    Lee, Ji Yeoun
    Wang, Kyu-Chang
    Lee, Chanhee
    Phi, Ji Hoon
    CANCER CELL INTERNATIONAL, 2016, 16
  • [30] Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)
    Bookhout, Christine
    Bouldin, Thomas W.
    Ellison, David W.
    NEUROPATHOLOGY, 2018, 38 (03) : 305 - 308